Guillain-Barré syndrome (GBS) is an uncommon autoimmune disorder characterized by progressive weakness and diminished deep tendon reflexes following infection or, rarely, vaccination.
the Zika virus epidemic in Puerto Rico, we conducted a casecontrol study to identify risk factors associated with GBS.
Methods | This study was approved by the US Centers for Disease Control and Prevention and the University of Puerto Rico institutional review boards. Written informed consent was obtained from participants.
Potential c ase-patients were reported to public health authorities from 9 reference hospitals throughout Puerto Rico with a clinical suspicion of GBS and neurologic illness onset from April 2016 through December 2016. Case-patients were offered enrollment within 1 month of reported neurologic illness onset. GBS diagnosis was retrospectively confirmed by chart review using the Brighton Collaboration criteria after hospital discharge. 4 Case-patients were matched to community controls 1:2 by age group (ie, 7-20, 21-39, 40-64, and >65 years) and place of residence (ie, ≤1-km radius from the residence of a casepatient). The control group included members of the community who lived continuously at the enrollment site for the previous 2 months and were enrolled within 1 week of the matched case-patient. Community control enrollment sites were identified using a randomly generated distance (ie, 0-1000 m) and degree from North (ie, 0°-359°) from each case-patient's residence.
For all participants, a questionnaire was administered on demographics, behaviors, exposures, and medical history, including acute illness within the previous 2 months, and serum, urine, and saliva specimens were collected. Participants were defined as having acute Zika virus infection if they had a positive reverse transcription-polymerase chain reaction (RT-PCR) result in any specimen. Participants were defined as having laboratory evidence of Zika virus infection if they had a positive RT-PCR result in any specimen or anti-Zika virus immunoglobulin M (IgM) detected in serum by enzyme-linked immunosorbent assay.
Using SAS (SAS Institute), version 9.3, the Pearson χ 2 test and 2 sample (2-sided) tests were used to analyze demographic variables. P values less than .05 were considered significant. Matched odds ratios (MORs) with 95% CIs were calculated to measure the association with risk factors, with CIs not including 1 considered significant.
Results | All 47 potential case-patients reported from the 9 hospitals were enrolled, and GBS neurologic diagnosis was confirmed for 39 case-patients (83%). Compared with the 78 controls, the 39 case-patients did not differ by age, but were more often male (Table) . Comparing case-patients and controls, identified GBS risk factors were acute illness within the previous 2 months (82% for case-patients vs 22% for controls; MOR, 12. Discussion | By prospectively enrolling potential GBS casepatients and collecting specimens soon after onset of neurologic illness, 3 GBS risk factors were identified: acute illness within the previous 2 months (consistent with GBS pathophysiology), any laboratory evidence of Zika virus infection (consistent with a case-control study conducted in French Polynesia 5 ), and acute Zika virus infection confirmed by RT-PCR. The latter finding adds to growing evidence of a causal association between Zika virus and GBS. This study was limited by a small sample size, which resulted in wide CIs, unknown generalizability, inability to routinely identify alternative GBS triggers (eg, Campylobacter jejuni), and inability to assess timing of infection. The predominance of males among case-patients could be due to sampling bias because sex is not statistically associated with GBS and there was a greater proportion of female GBS patients with evidence of Zika virus infection during the 2016 Zika virus epidemic in Puerto Rico. 6 The pathophysiology of Zika virus infection and risk factors for developing GBS require further investigation. Clinical trials of the Zika virus vaccine should monitor for GBS. During Zika virus outbreaks, clinical suspicion should be elevated to improve GBS patient prognosis through prompt diagnosis and treatment. 
COMMENT & RESPONSE

Acupuncture for Stress Urinary Incontinence
To the Editor A randomized clinical trial of women with stress urinary incontinence found that electroacupuncture reduced urinary leakage compared with sham electroacupuncture. 1 However, the electroacupuncture used in the study was not a typical acupuncture treatment. First, the authors did not make a traditional Chinese medicine diagnosis to determine the reason for the urinary leakage. A traditional Chinese medicine diagnosis is important to decide the acupuncture points to be used. If participants had a traditional Chinese medicine diagnosis of kidney deficiency or lung deficiency, more than 2 acupuncture points should have been used, but the authors only used 2 acupuncture points. Second, after 18 sessions of acupuncture treatment, the urine leakage was reduced from 18.4 g at baseline to 8.2 g at week 6 (55% reduction), whereas the number of participants using urine pads decreased from 119 at baseline to 115 during weeks 1 to 6 and to 72 during weeks 7 to 18 (39% reduction). Patients still needed to wear 40% of the number of pads they used at baseline after the 18 sessions of acupuncture, suggesting that the acupuncture procedure was only modestly effective.
Third, acupuncture is a highly personal skill. Finding the precise location of the 2 acupuncture points is not easy, especially for overweight patients. The authors did not mention how the quality of acupuncturists in the study was ensured.
Martin Wang, MD, PhD
